Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Altar

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Brain Research|January 7, 1994
Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3J A Siuciak, C A Altar, S J Wiegand, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1991
Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brainC A Altar, L E Burton, G L Bennett, et al.
Brain Research|June 4, 1984
Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injuryK A Neve, C A Altar, C A Wong, et al.
Journal of Neuroscience Methods|March 1, 1984
Computer-assisted video analysis of [3H]spiroperidol binding autoradiographsC A Altar, R J Walter, K A Neve, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonistsL H Jiang, R J Kasser, C A Altar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 22, 1998
Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatumD M Yurek, S B Hipkens, S J Wiegand, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1993
Characterization and topography of high-affinity 125I-neurotrophin-3 binding to mammalian brainC A Altar, M R Criden, R M Lindsay, et al.
The Journal of Clinical Investigation|January 1, 1992
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissuesL B Jakeman, J Winer, G L Bennett, et al.
Brain Research|February 26, 1996
BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administrationJ A Siuciak, C Boylan, M Fritsche, et al.
Molecular Pharmacology|June 1, 1988
Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonistsC A Altar, B Berner, P Beall, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Brain Research|January 7, 1994
Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3J A Siuciak, C A Altar, S J Wiegand, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1991
Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brainC A Altar, L E Burton, G L Bennett, et al.
Brain Research|June 4, 1984
Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injuryK A Neve, C A Altar, C A Wong, et al.
Journal of Neuroscience Methods|March 1, 1984
Computer-assisted video analysis of [3H]spiroperidol binding autoradiographsC A Altar, R J Walter, K A Neve, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonistsL H Jiang, R J Kasser, C A Altar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 22, 1998
Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatumD M Yurek, S B Hipkens, S J Wiegand, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1993
Characterization and topography of high-affinity 125I-neurotrophin-3 binding to mammalian brainC A Altar, M R Criden, R M Lindsay, et al.
The Journal of Clinical Investigation|January 1, 1992
Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissuesL B Jakeman, J Winer, G L Bennett, et al.
Brain Research|February 26, 1996
BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administrationJ A Siuciak, C Boylan, M Fritsche, et al.
Molecular Pharmacology|June 1, 1988
Dopamine release and metabolism after chronic delivery of selective or nonselective dopamine autoreceptor agonistsC A Altar, B Berner, P Beall, et al.
Pageof 10